Latest News for: bios

Edit

ABL Bio Receives Upfront Payment for License, Research and Collaboration Agreement for Grabody Platform and ...

Canada Newswire 26 Dec 2025
ABL Bio and Lilly are currently conducting joint research and development on multiple therapeutic candidates leveraging the Grabody platform across various modalities ... About ABL Bio ... SOURCE ABL Bio, Inc.
Edit

ABL Bio Receives Upfront Payment for License, Research and Collaboration Agreement for Grabody Platform and Equity Investment from Lilly

PR Newswire 26 Dec 2025
ABL Bio and Lilly are currently conducting joint research and development on multiple therapeutic candidates leveraging the Grabody platform across various modalities ... About ABL Bio ... SOURCE ABL Bio, Inc.
Edit

CHRISTMAS DAY NATIONAL BROADCAST MESSAGE BY HIS EXCELLENCY DR JULIUS MAADA BIO PRESIDENT OF THE REPUBLIC OF SIERRA LEONE THURSDAY, DECEMBER 25, 2025 (Government of the Republic of Sierra Leone)

Public Technologies 25 Dec 2025
) December 25, 2025 12.46 pm No Comments ... Disclaimer ... (noodl. 128631871) .
Edit

Sierra Leone’s President Bio Attends Christmas Day Mass In Bonthe, Reaffirms Commitment To Island Development (Government of the Republic of Sierra Leone)

Public Technologies 25 Dec 2025
Julius Maada Bio has reaffirmed his Government's commitment to the sustainable development of Bonthe Island, as he attended the Holy Mass marking Christmas Day at the Catholic Church on Bonthe Island.
Edit

Gundry MD Bio Complete 3 Reviews: 2,400+ Positive Reviews, Users Rave About Improved Digestion, Energy ...

Morgan Citizen 24 Dec 2025
Why Dr. Steven Gundry's Probiotic, Prebiotic & Postbiotic "Triple-Action" Formula is Transforming Gut Health and Boosting Overall Wellness*✝ ... .
Edit

Vor Bio Appoints RA Capital’s Andrew Levin, M.D., Ph.D., and Forbion’s Wouter Joustra to Board

Enid News & Eagle 24 Dec 2025
BOSTON, Mass., Dec ... (Nasdaq.
Edit

OCEN BIO Stem Cell Treatments Bridges the Gap Between Biology and Beauty

GetNews 24 Dec 2025
Today, OCEN BIO Stem Cell Treatments are erasing that divide ... But at OCEN BIO, we understand that the exterior is just a reflection of the foundation ... About OCEN BIO Stem Cell Treatments ... OCEN BIO.
Edit

NEXTCHEM (MAIRE) to acquire 100% of Ballestra Group, composed of Ballestra S.P.A. (Italy), Buss Chemtech Ag (Switzerland) and Ballestra Engineering and Projects Pvt (India), with approximately 450 employees, expanding its intellectual property and technology portfolio in sustainable fertilizers, bio-based detergents, including the well-known Mazzoni brand, fluorine derivatives and gas-liquid reactors design for chemical specialties (Maire SpA)

Public Technologies 24 Dec 2025
... AND TECHNOLOGY PORTFOLIO IN SUSTAINABLE FERTILIZERS, BIO-BASED DETERGENTS, INCLUDING THE WELL-KNOWN MAZZONI BRAND, FLUORINE DERIVATIVES AND GAS-LIQUID REACTORS DESIGN FOR CHEMICAL SPECIALTIES.
Edit

Secura Bio Announces Participation in Gilmartin Group’s 2026 Corporate Access Event in San Francisco

Nasdaq Globe Newswire 23 Dec 2025
BERKELEY HEIGHTS, N.J., Dec. 23, 2025 (GLOBE NEWSWIRE) -- Secura Bio, Inc ... .
Edit

Beneficial Ownership Report (Form SC 13G) (Propel Bio Management LLC)

Public Technologies 23 Dec 2025
Propel Bio Management LLC published this content on December 23, 2025, and is ...
Edit

Material Agreement (Form 8-K) (INmune Bio Inc)

Public Technologies 23 Dec 2025
). Item 1.01 Entry into a Material Definitive Agreement. On December 22, 2025, INmune Bio Inc ... As consideration for the Warrant Amendment, the holders paid the Company $0.05 per April 2024 Warrant, for aggregate proceeds of $67,416 ... INmune Bio Inc.
Edit

Biometric Identification / Cybersecurity SaaS Solutions Provider BIO-key Presents at DealFlow Discovery Investor Conference Jan. ...

Nasdaq Globe Newswire 23 Dec 2025
$BKYI. Biometric Identification / Cybersecurity SaaS Solutions Provider BIO-key Presents at DealFlow Discovery Investor Conf. Jan. 28/29 in Atlantic City ... .
Edit

Entera Bio Congratulates the FNIH-ASBMR-SABRE Team on FDA’s Qualification of Total Hip BMD as Regulatory ...

Nasdaq Globe Newswire 23 Dec 2025
FDA qualification of Total Hip BMD as a validated surrogate endpoint for novel osteoporosis drug development further bolsters Entera's July 2025 FDA alignment and regulatory strategy for EB613 ... .
Edit

Bio-Techne to Present at the 2026 J.P. Morgan Healthcare Conference

PR Newswire 23 Dec 2025
23, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ ... A live webcast of the presentation can be accessed via the IR Calendar page of Bio-Techne's Investor Relations website at https.//investors.bio-techne.com/ir-calendar.
Edit

Proxy Results (Form 8-K) (Mustang Bio Inc)

Public Technologies 23 Dec 2025
). Item 5.07Submission of Matters to a Vote of Security Holders. ​. Mustang Bio, Inc ... Eastern Time. At the 2025 Annual Meeting, the following four proposals were approved ... ​ ... ​. Proposal 1. ​ ... ​ ... ​. For ... As previously disclosed, Mustang Bio, Inc ... Mustang Bio Inc.

Article Search

tools
×
×
×
×